{"name":"Institut fuer Frauengesundheit","slug":"institut-fuer-frauengesundheit","ticker":"","exchange":"","domain":"","description":"Institut fuer Frauengesundheit is a specialized pharmaceutical company focused on women's health, with a portfolio that includes two marketed drugs in oncology. The company is dedicated to advancing treatments and improving outcomes for patients.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Eribulin Injection [Halaven]","genericName":"Eribulin Injection [Halaven]","slug":"eribulin-injection-halaven","indication":"Other","status":"marketed"},{"name":"Ontruzant","genericName":"Ontruzant","slug":"ontruzant","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Eribulin Injection [Halaven]","genericName":"Eribulin Injection [Halaven]","slug":"eribulin-injection-halaven","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ontruzant","genericName":"Ontruzant","slug":"ontruzant","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}